Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoposide in COVID-19
NCT04356690Phase 2Terminated
- Sponsor
- Boston Medical Center
- Start
- May 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide in coronavirus disease 2019 (COVID-19), sponsored by Boston Medical Center. Started May 2020; status: terminated.
02
Drugs
etoposide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04356690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356690.